MarginsXMarginsX
Home › Markets › Health Care › PLSM

Pulsenmore Ltd. (PLSM)

PLSM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.41
+2.17% on the day
Market cap
$9.2M
Nano cap
Revenue · 2025
$12.5M
No prior year to compare
Net income · 2025
-$5.0M
-39.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/2064764/000149315226013485/0001493152-26-013485-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerPLSM on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0002064764

Financials · 2025

LineValue
Revenue$12.5M
Net income-$5.0M
Operating incomeNot in SEC XBRL data
Net margin-39.6%
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$6.8M
Total assets$31.9M
P/E (computed)Net income was not positive
P/S (computed)0.7×

Warning signs

Cash runway
7.9 months
$6.8M cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
No
20-F filed March 30, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-30
Cash and burn$6.8M cash; operating cash flow -$2.6M a quarter.Report 2025-12-31
Shares outstanding6,502,844 (2026-03-15). the newest SEC cover-page count is from 2026-03-15; shares issued since then are not in these figures.Cover page 2026-03-15
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKesselman & Kesselman C.P.A.s, Tel-Aviv, IsraelPCAOB Form AP 2026-04-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$12.5M-$5.0M-$10.3M$6.8MNo debt tags$12.5M20-F 2026-03-30

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-8.6%
1 month-27.4%
3 months-54.3%
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-81.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SINTSiNtx Technologies Inc.$1.34-1.11%$10.1M
AEMDAethlon Medical Inc.$5.01-5.29%$8.1M
ARAYAccuray Incorporated$2.55-8.93%$7.7M
FEMYFemasys Inc.$1.28-8.57%$11.1M
CNSYCerenome Inc. Common Stock$0.7148-24.77%$7.0M
NMTCNeuroOne Medical Technologies Corporation$0.7450-0.01%$6.8M
DRIODarioHealth Corp.$1.15-8.73%$13.0M
GUTSFractyl Health Inc.$0.9918+9.76%$13.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier